home / stock / sngx / sngx news

SNGX News and Press, Soligenix Inc. From 08/13/19

Stock Information
Company Name: Soligenix Inc.
Stock Symbol: SNGX
Market: NASDAQ
Website: soligenix.com
Menu
SNGX SNGX Quote SNGX Short SNGX News SNGX Articles SNGX Message Board
Get SNGX Alerts

News, Short Squeeze, Breakout and More Instantly...
SNGX - Soligenix EPS beats by $0.02, beats on revenue

Soligenix (NASDAQ: SNGX ): Q2 GAAP EPS of -$0.12 beats by $0.02 . More news on: Soligenix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SNGX - Soligenix Announces Recent Accomplishments And Second Quarter 2019 Financial Results

PRINCETON, N.J. , Aug. 13, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its r...

SNGX - Soligenix: High Risk, High Reward

Soligenix ( SNGX ) has a wide pipeline with late-stage candidates in the PDT treatment for various health problems, including Cutaneous T-Cell Lymphoma ((CTCL)), Oral Mucositis, Pediatric Crohn's Disease, and a vaccine candidate for ricin. Unfortunately, the company hasn't managed to bring any...

SNGX - Soligenix Announces Conference Presentations Demonstrating Formulations of Single and Multivalent Ebola Subunit Vaccines

PRINCETON, N.J. , July 31, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that ...
SNGX - MYL, GRUB among premarket gainers

Medley Management (NYSE: MDLY ) +35%  as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...

SNGX - Soligenix nabs two patents in Europe

The European Patent Office has issued two patents to Soligenix (NASDAQ: SNGX ), both titled "Topically Active Steroids for use in Radiation and Chemotherapeutics Injury" with the latest issuing October 24, 2018, following the expiration of the objection period as of July 24, 2019. More n...

SNGX - Soligenix Receives European Patents for Oral BDP in the Treatment of Acute Radiation Injury of the Gastrointestinal Tract

PRINCETON, N.J. , July 29, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the E...
SNGX - Soligenix Announces Appointment of Diane L. Parks to its Board of Directors

PRINCETON, N.J. , July 8, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced t...

SNGX - Soligenix to Present RiVax® Program at the 13?? Annual CounterACT Network Research Symposium

PRINCETON, N.J. , June 13, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that ...

SNGX - Soligenix awarded a subcontract of $600,000 for supporting evaluation of IDR platform technology

Soligenix (NASDAQ: SNGX ) will be participating in a biodefense contract for the development of medical countermeasures against bacterial threat agents, with Soligenix awarded a subcontract of ~$600,000 over 3 years. More news on: Soligenix, Inc., Healthcare stocks news, Read more .....
Previous 10 Next 10